Article info
Cancer genetics
Original article
Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA
- Correspondence to Dr Fenglei Yu, Department of Thoracic Surgery, Second Xiangya Hospital, Changsha, China; yufenglei{at}csu.edu.cn, Dr Chuanbo Xu, Vienomics Corp. Ltd, Shenzhen 95129, China; xcb{at}vienomics.com and Dr Geng Tian, Department of Medical Oncology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China; tiangeng666{at}aliyun.com
Citation
Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA
Publication history
- Received October 23, 2018
- Revised February 12, 2019
- Accepted March 5, 2019
- First published April 13, 2019.
Online issue publication
October 05, 2019
Article Versions
- Previous version (23 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.